Background/Aims: The secretion and regulation of several hormones such as leptin and growth hormone (GH) is sexually dimorphic. Gender effects on ghrelin, a hormone involved in the regulation of GH secretion and appetite control, are controversial. Our aim was to study the relationship between plasma ghrelin and serum sex steroid hormone concentrations. Methods: Forty-five subjects (19 men, 12 premenopausal and 14 postmenopausal women) were evaluated at the Institute of Endocrinology and Metabolism, Tel Aviv Sourasky Medical Center, Israel. After an overnight fast, blood samples were collected for measurements of ghrelin, testosterone, bioavailable testosterone (BT) and estradiol. Statistical analysis was performed with adjustments for age and body mass index. Results are given as mean ± standard deviation. Results: Ghrelin levels were significantly higher in women (510 ± 489 pg/ml) than in men (319 ± 237 pg/ml; p = 0.02). There was a positive correlation between ghrelin and both total testosterone (r = 0.5, p = 0.039) and BT (r = 0.719, p = 0.0011) in male subjects. In premenopausal women, no significant correlations were found between ghrelin and testosterone or BT (r = –0.39, p = 0.2). In contrast, ghrelin strongly and positively correlated with total testosterone (r = 0.7, p = 0.01) and BT (r = 0.821, p = 0.001) in postmenopausal women. Estradiol and ghrelin were positively correlated in the group as a whole (r = 0.356, p = 0.019), but not significantly when analyzed separately by gender. Conclusions: Circulating ghrelin in humans is sexually dimorphic. Testosterone correlates positively with ghrelin levels in men and postmenopausal women.

Keywords:
Testosterone, Ghrelin, Growth hormone
1.
Meinhardt UJ, Ho KK: Regulation of growth hormone action by gonadal steroids. Endocrinol Metab Clin North Am 2007;36:57–73.
2.
Jaffe CA, Ocampo-Lim B, Guo W, Krueger K, Sugahara I, DeMott-Friberg R, Bermann M, Barkan AL: Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J Clin Invest 1998;102:153–164.
3.
Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER: Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 1993;76:996–1001.
4.
Weissberger AJ, Ho KK: Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab 1993;76:1407–1412.
5.
Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO: Both oral and transdermal estrogen increase growth hormone release in postmenopausal women – a clinical research center study. J Clin Endocrinol Metab 1996;81:2250–2256.
6.
Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, el-Tawil K, Rude RK, Kamdar V: Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 1997;82:579–584.
7.
Luukkaa V, Pesonen U, Huhtaniemi I, Lehtonen A, Tilvis R, Tuomilehto J, Koulu M, Huupponen R: Inverse correlation between serum testosterone and leptin in men. J Clin Endocrinol Metab 1998;83:3243–3246.
8.
Elbers JM, Asscheman H, Seidell JC, Frölich M, Meinders AE, Gooren LJ: Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab 1997;82:3267–3270.
9.
Gaulillo O, Caminos JE, Kojima M, Kangawa K, Arvat E, Ghigo E, Casanueva FF, Dieguez C: Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur J Endocrinol 2001;144:687–690.
10.
Liu LY, Yakar S, Otero-Corchon V, Low MJ, Liu JL: Ghrelin gene expression is age-dependent and influenced by gender and the level of circulating IGF-1. Mol Cell Endocrinol 2002;189:97–103.
11.
Matsubara M, Sakata I, Wada R, Yanazaki M, Inoue K, Sakai T: Estrogen modulates ghrelin expression in the female rat stomach. Peptides 2004;25:289–297.
12.
Sakata I, Tanaka T, Yamazaki M, Tanizaki T, Zheng Z, Sakai T: Gastric estrogen directly induces ghrelin expression and production in rat stomach. J Endocrinol 2006;190:749–757.
13.
Barkan AL, Dimaraki, EV, Jessup SK, Symons KV, Ermolenko M, Jaffe CA: Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 2003;88:2180–2184.
14.
Greenman Y, Golani N, Gilad S, Yaron M, Limor R, Stern N: Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin Endocrinol 2004;60:382–388.
15.
Makovey J, Naganathan V, Seibel M, Sambrook P: Gender differences in plasma ghrelin and its relations to body composition and bone – an opposite-sex twin study. Clin Endocrinol 2007;66:530–537.
16.
Akamizu T, Shinomiya T, Irako T, Fukunaga M, Nakai Y, Nakai Y, Kangawa K: Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 2005;90:6–9.
17.
Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML: Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707–709.
18.
Purnell JQ, Weigle DS, Breen P, Cummings DE: Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status or cortisol levels in humans. J Clin Endocrinol Metab 2003;88:5747–5752.
19.
Broglio F, Benso A, Castiglioni C, Gottero C, Prodam F, Destefanis S, Gauna C, van der Lely AJ, Deghenghi R, Bo M, Arvat E, Ghigo E: The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 2003;88:1537–1542.
20.
Trembley RR, Dube JY: Plasma concentrations of free non-TeBG bound testosterone in women on oral contraception. Contraception 1974;10:599–605.
21.
Greenman Y, Tordjman K, Kisch E, Razon N, Ouaknine G, Stern N: Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas. J Clin Endocrinol Metab 1995;80:1577–1583.
22.
Pagotto U, Gambineri A, Pelusi C, Genghini S, Cacciari M, Otto B, Castaneda T, Tschöp M, Pasquali R: Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J Clin Endocrinol Metab 2003;88:4139–4143.
23.
Schöfl C, Horn R, Schill T, Schlösser HW, Müller MJ, Brabant G: Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:4607–4610.
24.
Pagotto U, Gambineri A, Vicennati V, Heiman ML, Tschöp M, Pasquali R: Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab 2002;87:5625–5629.
25.
Glintborg D, Andersen M, Hagen C, Frystyk J, Hulstrom V, Flyvbjerg A, Hermann AP: Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 2006;155:337–345.
26.
Orio F, Lucidi P, Palomba S, Tauchmanova L, Cascella T, Russo T, Zullo F, Colao A, Lombardi G, De Feo P: Circulating ghrelin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:942–945.
27.
Kellokoski E, Pöykkö SM, Karjalainen AH, Ukkola O, Heikkinen J, Kesäniemi YA, Hörkkö S: Estrogen replacement therapy increases plasma ghrelin levels. J Clin Endocrinol Metab 2005;90:2954–2963.
28.
Tena-Sempere M: Ghrelin and reproduction: ghrelin as novel regulator of the gonadotropic axis. Vit Horm 2008;77:285–300.
29.
Fernandez-Fernandez T, Tena-Sempere M, Navarro V, Barreiro ML, Castellano JM, Aguilar E, Pinilla L: Effects of ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: in vivo and in vitro studies. Neuroendocrinol 2005;82:245–255.
30.
Fernandez-Fernandez R, Tena-Sempere M, Roa J, Castellano JM, Navarro VM, Aguilar E, Pinilla L: Direct stimulatory effect of ghrelin on pituitary release of LH through a nitric oxide-dependent mechanism that is modulated by estrogen. Reproduction 2007;133:1223–1232.
31.
Kluge M, Schüssler P, Uhr M, Yassouridis A, Steiger A: Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab 2007;92:3202–3205.
32.
Tolle V, Kadem M, Bluet-Pajot M, Frere D, Foulon C, Bossu C, Dardennes R, Mounier C, Zizzari P, Lang F, Eppelbaum J, Estour B: Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 2003;88:109–116.
33.
De Souza MJ, Leidy HJ, O’Donnell E, Lasley B, Williams NI: Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004;89:3536–3542.
34.
Vulliemoz NR, Xiao E, Xia-Zhang L, Rivier J, Ferin M: Astressin B, a nonselective corticotrophin-releasing hormone receptor antagonist, prevents the inhibitory effect of ghrelin on luteinizing hormone pulse frequency in the ovariectomized rhesus monkey. Endocrinology 2008;149:869–874.
35.
Tena-Sempere M, Barreiro ML, González LC, Gaytán F, Zhang FP, Caminos JE, Pinilla L, Casanueva FF, Diéguez C, Aguilar E: Novel expression and functional role of ghrelin in rat testis. Endocrinology 2002;143:717–725.
36.
Gaytán F, Morales C, Barreiro ML, Jeffery P, Chopin LK, Herington AC, Casanueva FF, Aguilar E, Dieguez C, Tena-Sempere M: Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors. J Clin Endocrinol Metabol 2005;90:1798–1804.
37.
Guanapavan S, Kola B, Burstin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter T, Grossman AB, Korbonits M: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metabol 2002;87:2988–2991.
38.
Gambineri A, Pagotto U, De Lasio R, Meriggiola MC, Constantino A, Patton L, Pelusi C, Pelusi G, Pasquali R: Short term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. J Endocrinol Invest 2005;28:241–246.
39.
Martini AC, Fernandez-Fernandez R, Tovar S, Navarro VM, Vigo E, Vazquez MJ, Davies JS, Thompson NM, Aguilar E, Pinilla L, Wells T, Dieguez C, Tena-Sempere M: Comparative analysis of the effects of ghrelin and unacylated ghrelin on luteinizing hormone secretion in male rats. Endocrinology 2006;147:2374–2386.
40.
Pöykkö SM, Kellokoski E, Hörkkö S, Kauma H, Kesäniemi YA, Ukkola O: Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003;52:2546–2553.
41.
Öner-Iyidoğan Y, Koçak H, Gürdöl F, Öner P, Işsever H, Esin D: Circulating ghrelin levels in obese women: a possible association with hypertension. Scand J Clin Lab Invest 2007;67:568–576.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.